Delivery Order SPE2DB20D2002-SPE2DB23FL34T
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The $1,143.36 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The contract has a ceiling value of $2,287.42 and a period of performance through May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing...
- This award from the Defense Logistics Agency (DLA) is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Difluprednate 0.05% eye drops in 5 mL packaging, with a ceiling value of $2,286.72 and a performance period through February 23, 2023. This contract does not have a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,680.85, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,309.01 firm fixed-price contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. The contract has a completion date of June 7, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This contract award, valued at $3,179.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Difluprednate 0.05% eye drops in 5ml quantities. This is a firm-fixed price delivery order contract with a completion date of February 14, 2023. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a $1,362.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a specialty medication, to support military healthcare programs. The delivery order has a completion date of June 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.76 firm fixed-price delivery order is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a prescription medication. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. There was no set-aside designation for this award. Amerisourcebergen holds a large Indefinite...
- The Defense Logistics Agency awarded a $1,043.01 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Difluprednate 0.05% eye drops in 5ml quantities. This firm fixed-price contract, which carries an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be...
- This federal contract award, with an ID of SPE2DB22D2007|SPE2DB23FJ2DK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 5 ml bottles of the eye drop medication Difluprednate 0.05%. The award is a Firm Fixed Price Delivery Order with a ceiling value of $8,254.51 and an ultimate completion date of May 5, 2023. Amerisourcebergen holds a significant Indefinite...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL34TDelivery Order
This federal contract award, with an ID of SPE2DB20D2002|SPE2DB23FL34T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,701.72 delivery order is for the supply of Difluprednate 0.05% eye drop, a prescription medication, to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/19/23 |